Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Is Teva About to Tear Itself Apart?
Motley Fool
Saturday, April 14, 2012 - 1:16pm
tags:
Teva Pharmaceuticals
Intellipharmaceutics Announces First Quarter 2012 Results
4-Traders
Saturday, April 14, 2012 - 1:05pm
tags:
Intellipharmaceutics
Gilead Sciences: Highest Returning Protected Covered Call
Seeking Alpha
Saturday, April 14, 2012 - 1:04pm
tags:
Gilead Sciences
Deals Of The Week: Will Lightning Strike Twice At Shire
In Vivo Blog
Saturday, April 14, 2012 - 1:03pm
tags:
Shire, Pervasis Therapeutics, regenerative medicine
AstraZeneca works toward tropical disease cures
Delaware Online, DE
Saturday, April 14, 2012 - 1:01pm
tags:
AstraZeneca, Chagas disease, leishmaniasis
Catalent pairs with BASF on biovailability challenges
NJ Biz, NJ
Saturday, April 14, 2012 - 12:58pm
tags:
Catalent, BASF
Pharma companies cozy up to VC firms
Mass HiTech
Saturday, April 14, 2012 - 12:56pm
tags:
Mylan Launches First Generic Version of Lescol® Capsules
Health Care Global
Saturday, April 14, 2012 - 12:46pm
tags:
Mylan, Lescol, Novartis, generics
More Hair, Less Reason for It
Motley Fool
Saturday, April 14, 2012 - 12:42pm
tags:
Merck, Propecia, sexual dysfunction
Biogen's Fampyra Launched in Canada
Yahoo/Zacks
Saturday, April 14, 2012 - 12:39pm
tags:
Biogen Idec, Fampyra, multiple sclerosis
Ample Supplies of Shingles Vaccine Return
WSJ
Saturday, April 14, 2012 - 12:38pm
tags:
shingles, Merck, Zostavax
Are Merck’s Top Investors Waiting for Catalysts to Bid Shares Higher in 2012?
Wall St. Cheat Sheet
Saturday, April 14, 2012 - 12:37pm
tags:
Merck
Pfizer, OSI Sue Roxane Over Generic Tarceva Cancer Drug
Bloomberg
Saturday, April 14, 2012 - 12:36pm
tags:
Pfizer, OSI Pharmaceuticals
J&J’s Gorsky Should Be Forced to Testify in Suit, U.S. Says
Bloomberg
Saturday, April 14, 2012 - 12:33pm
tags:
JNJ, Alex Gorsky, legal, lawsuit
Abbott Laboratories First Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Saturday, April 14, 2012 - 12:31pm
tags:
Abbott Laboratories, earnings
It's Fashionably Late, but This Biotech's Party Is Just Starting
Motley Fool
Saturday, April 14, 2012 - 12:27pm
tags:
Seattle Genetics, Adcetris, Hodgkin's lymphoma, anaplastic large-cell lymphoma
Vivus Could Surge On Qnexa Approval
Motley Fool
Saturday, April 14, 2012 - 12:25pm
tags:
Vivus, Qnexa, obesity
Questcor Could Shoot Higher On Acthar's Versatility
Motley Fool
Saturday, April 14, 2012 - 12:23pm
tags:
Questcor, Acthar, multiple sclerosis, nephrotic syndrome, infantile spasms
Optimer Pharma Evenly Poised
Yahoo/Zacks
Saturday, April 14, 2012 - 12:22pm
tags:
Optimer Pharmaceuticals
2 Attractive Biotech Stocks, With Good Entry Points
Seeking Alpha
Saturday, April 14, 2012 - 12:21pm
tags:
Horizon Pharma, Duexis, Lodotra, arthritis, rheumatoid arthritis, pain management

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.